UKM inks MoA to advance cancer treatment

Meaningful collaboration: (from left) UKM Faculty of Medicine dean Prof Dr Abdul Halim Abdul Gafor, Prof Dr Wan Kamal, Dr Park, and NK Biocell medical director Dr Lan Leong Chung.

UNIVERSITI Kebangsaan Malaysia (UKM) is working towards advancing cancer treatment under a new collaboration with NK Biocell Sdn Bhd.

The memorandum of agreement (MoA), signed at Hospital Universiti Kebangsaan Malaysia (HUKM) recently, has the potential to offer hope for cancer patients in Malaysia who are seeking treatment other than chemotherapy.